TABLE 1.
Cancer | Method | Ref. | Differential diagnosis | Diagnosis | Monitoring | Classification/staging | ||||||||
Sens. | Spec. | Acc. | Sens. | Spec. | Acc. | Sens. | Spec | Acc. | Sens. | Spec. | Acc. | |||
Lung | Low-dose CT | [2, 3] | 80–100 | >90 | 52–65 | 48–79 | PPV 100 | 52–91 | 48–95 | PPV 79; NPV 78–93 |
||||
Breath analysis | [4–9] | 60–100 | 57–100 | 59–94 | 70–91 | 73–88 | 88 | 28–93 | 75–100 | 80–92 | 78–92 | 73–95 | 83–88 | |
Breast | Mammography | [10, 11] | 93–96 | 89–93 | 71–87 | 42–88 | 75–92 | 70 | ||||||
Breath analysis | [12, 13] | 63–94 | 76–82 | 71–88 | 71–100 | 70–100 | 71–100 | |||||||
Ovarian | CA125 and TVU | [14] | 77–89 | 75–99 | ||||||||||
Breath analysis | [15, 16] | 59–83 | 61–100 | 61–89 | ||||||||||
Gastric | Gastroscopy | [17] | 69–84 | 85–96 | ||||||||||
Breath analysis | [18–21] | 71–97 | 87–91 | 77–96 | 73–96 | 98 | 92–95 | 45–93 | 41–98 | 43–92 | ||||
Colorectal | Colonoscopy | [22, 23] | 66–99 | 30–100 | 70–96 | 88–98 | 82–99 | |||||||
Breath analysis | [24] | 85 | 94 | 91 | 100 | 88 | 94 |
Data are presented as percentages and represent either a range of results (when more than one study is included) or a single result (when only one study tested the specific application). Sens.: sensitivity; Spec.: specificity; Acc.: accuracy; CT: computed tomography; TVU: transvaginal ultrasound; PPV: positive predictive value; NPV: negative predictive value. #: data based on selected representative studies rather than a comprehensive literature review.